0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 261-280 of 516 Articles
Editor's Correspondence | 
Nicholas S. Downing, AB; Joseph S. Ross, MD, MHS; Harlan M. Krumholz, MD, SM
Arch Intern Med. 2012;172(19):1522-1523. doi:10.1001/2013.jamainternmed.806.

Editor's Correspondence | 
Raffaele Marfella, MD, PhD; Carlo Carella, MD; Giuseppe Paolisso, MD, PhD
Arch Intern Med. 2012;172(19):1523-1524. doi:10.1001/archinternmed.2012.4409.

Editor's Correspondence | 
Salman Razvi, MD, FRCP; Simon H. S. Pearce, MD, FRCP
Arch Intern Med. 2012;172(19):1523-1524. doi:10.1001/2013.jamainternmed.597.

Invited Commentary | 
Chee M. Chan, MD, MPH; Andrew F. Shorr, MD, MPH
Arch Intern Med. 2012;172(18):1375-1376. doi:10.1001/archinternmed.2012.3650.

Invited Commentary | 
James S. Floyd, MD, MS; Bruce M. Psaty, MD, PhD
Arch Intern Med. 2012;172(18):1412-1414. doi:10.1001/archinternmed.2012.4306.

Editor's Correspondence | 
Kim L. Lavoie, PhD; Tavis S. Campbell, PhD; Simon L. Bacon, PhD
Arch Intern Med. 2012;172(17):1351-1352. doi:10.1001/archinternmed.2012.2575.

Editor's Correspondence | 
Daniel H. Solomon, MD, MPH; Maura Daly Iversen, PT, DPT, SD, MPH; Jeffrey N. Katz, MD, MSc
Arch Intern Med. 2012;172(17):1351-1352. doi:10.1001/archinternmed.2012.3409.

Editor's Correspondence | 
James M. Wright, MD, PhD, CRCP(C); Ken L. Bassett, MD, PhD; Aaron M. Tejani, BSc(Pharm), PharmD
Arch Intern Med. 2012;172(17):1352-1353. doi:10.1001/archinternmed.2012.3723.

Research Letters |  FREE
Raman Ravi Khanna, MD, MAS; Ronald G. Victor, MD; Kirsten Bibbins-Domingo, PhD, MD; et al.
Arch Intern Med. 2012;172(17):1344-1345. doi:10.1001/archinternmed.2012.2749.
Includes: Supplemental Content

Research Letters |  FREE
Abeer Ahmad, MSc; Giel Nijpels, MD, PhD; Jacqueline M. Dekker, PhD; et al.
Arch Intern Med. 2012;172(17):1346-1347. doi:10.1001/archinternmed.2012.2816.

Commentary | 
Jane C. Ballantyne, MD, FRCA; Mark D. Sullivan, MD, PhD; Andrew Kolodny, MD
Arch Intern Med. 2012;172(17):1342-1343. doi:10.1001/archinternmed.2012.3212.

Original Investigation |  FREE
Luigia Elzi, MD, MSc; Stefan Erb, MD; Hansjakob Furrer, MD; et al.
Arch Intern Med. 2012;172(17):1313-1321. doi:10.1001/archinternmed.2012.3216.

Invited Commentary | 
Daniel R. Kuritzkes, MD
Arch Intern Med. 2012;172(17):1321-1323. doi:10.1001/archinternmed.2012.3644.

Research Letters |  FREE
Christopher M. Jones, PharmD, MPH
Arch Intern Med. 2012;172(16):1265-1267. doi:10.1001/archinternmed.2012.2533.

Research Letters |  FREE
Giordano Egiziano, BSc; Louise Pilote, MD, PhD, MPH; Hassan Behlouli, PhD; et al.
Arch Intern Med. 2012;172(16):1263-1265. doi:10.1001/archinternmed.2012.2514.

Invited Commentary | 
Peter W. Groeneveld, MD, MS
Arch Intern Med. 2012;172(15):1152-1153. doi:10.1001/archinternmed.2012.2724.

Original Investigation |  FREE
Amit P. Amin, MD, MSc; John A. Spertus, MD, MPH; David J. Cohen, MD, MSc; et al.
Arch Intern Med. 2012;172(15):1145-1152. doi:10.1001/archinternmed.2012.3093.
Includes: Supplemental Content

Editor's Correspondence | 
Vijay Krishnamoorthy, MD; Paul Bhalla, MBChB, FRCA
Arch Intern Med. 2012;172(15):1189-1190. doi:10.1001/archinternmed.2012.2085.

Editor's Correspondence | 
Asim Alam, MD; Tara Gomes, MHSc; Chaim M. Bell, MD, PhD
Arch Intern Med. 2012;172(15):1189-1190. doi:10.1001/archinternmed.2012.2897.

Invited Commentary | 
Peter J. Kaboli, MD, MS; Olavo Fernandes, BScPhm, PharmD
Arch Intern Med. 2012;172(14):1069-1070. doi:10.1001/archinternmed.2012.2667.

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Review  | 
Novel Methods and Technologies for 21st-Century Clinical Trials:  A Review
E. Ray Dorsey, MD, MBA; Charles Venuto, PharmD; Vinayak Venkataraman, BSE; et al.
JAMA Pediatrics
Viewpoint  | 
A Landmark Report on Improving Medicines for Children
Geert W. ‘t Jong, MD, PhD; Terry P. Klassen, MD, MSc, FRCPC; Stuart M. MacLeod, BSc(Med), MD, PhD, FRCPC
JAMA Pediatrics
Editorial  | 
Twelve-Dose Drug Regimen Now Also an Option for Preventing Tuberculosis in Children and Adolescents
Ben J. Marais, PhD
JAMA Pediatrics
Original Investigation  | 
Treatment for Preventing Tuberculosis in Children and Adolescents:  A Randomized Clinical Trial of a 3-Month, 12-Dose Regimen of a Combination of Rifapentine and Isoniazid
M. Elsa Villarino, MD, MPH; Nigel A. Scott, MS; Stephen E. Weis, DO; et al.